Lung Cancer Clinical Trials

A listing of Lung Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 239 clinical trials
Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection

It is our hypothesis that a course of Ta1 administered to hospitalized individuals with COVID-19 infection and lymphocytopenia will improve the time to recovery (primary objective) and severity of infection (secondary objectives) compared to untreated individuals in the same hospital with comparable lymphocytopenia. After screening, hospitalized patients with COVID-19 and …

lymphopenia
  • 0 views
  • 22 Sep, 2021
  • 1 location
A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer

administered as an infusion under the skin acts similarly to durvalumab administered into a vein. 24 participants with Non-Small Cell Lung Cancer will be enrolled for a 12 month treatment period and 3 months

durvalumab
etoposide
extensive disease
lung carcinoma
cancer chemotherapy
  • 0 views
  • 23 Sep, 2021
  • 20 locations
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

The purpose of this study is to assess the efficacy and safety of pembrolizumab in combination with concurrent chemoradiation therapy followed by either pembrolizumab with olaparib placebo (Arm 1) or with olaparib (Arm 2) compared to concurrent chemoradiation therapy followed by durvalumab (Arm 3) in participants with unresectable, locally advanced …

durvalumab
stage iii non-small cell lung cancer
pemetrexed
targeted therapy
lung cancer
  • 51 views
  • 23 Sep, 2021
  • 192 locations
Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003)

Solid Tumors (RECIST) 1.1 by blinded independent central review (BICR), and with respect to overall survival (OS), in participants with non-small cell lung cancer.

cancer
growth factor
epidermal growth factor receptor
EGFR
mk-3475
  • 0 views
  • 22 Sep, 2021
  • 50 locations
Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer and their families.

cancer
lung carcinoma
primary malignant neoplasm
lung cancer
  • 206 views
  • 23 Sep, 2021
  • 19 locations
Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250)

-resistant small-cell lung cancer (SCLC). This study will be conducted in two parts: safety run-in part and main part. The safety run-in part will be conducted in Japan.

topotecan
measurable disease
carboplatin
  • 0 views
  • 15 Sep, 2021
  • 21 locations
Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer

This phase III trial studies how well chemotherapy and radiation therapy (chemoradiation) with or without atezolizumab works in treating patients with limited stage small cell lung cancer. Drugs

  • 85 views
  • 25 Sep, 2021
  • 348 locations
A Trial to Compare the Efficacy Safety Pharmacokinetics and Immunogenecity of HD204 to Avastin in Advanced Non-squamous Non-small Cell Lung Cancer Patients

In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin. The aim of the study is to demonstrate equivalence of HD204 and EU-licensed Avastin in terms of efficacy, safety, pharmacokinetics and immunogenecity.

cancer
carboplatin/paclitaxel
bevacizumab
non-squamous non-small cell lung cancer
lung cancer
  • 80 views
  • 18 Sep, 2021
  • 23 locations
Study of Amivantamab a Human Bispecific EGFR and cMet Antibody in Participants With Advanced Non-Small Cell Lung Cancer

combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small cell lung cancer (NSCLC).

growth factor
pemetrexed
erlotinib
epidermal growth factor
cancer chemotherapy
  • 0 views
  • 23 Sep, 2021
  • 112 locations
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who progressed on First-Line Osimertinib Therapy. This study is modular in design, allowing evaluation of the efficacy

durvalumab
growth factor
pemetrexed
epidermal growth factor
lung adenocarcinoma
  • 64 views
  • 16 Sep, 2021
  • 47 locations